COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R) : Denominator PR

29/03/2018 - 07:01

C ommuniqué de presse Information réglementée 29 mars 2018, 7h00 HEC Nouveau Montant du Capital Social et Nouveau Nombre d'Actions de MDxHealth IRVINE, CA, et HERSTAL (BELGIQUE) - le 29 mars 2018 - MDxHealth SA ( [...]

Addex Sucessfully Raises CHF40 million in Capital Increase

29/03/2018 - 07:01

Geneva, Switzerland, 29 March 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that the company has successfully completed its [...]

Kiadis Pharma to announce Annual Results for the year ended December 31, 2017

29/03/2018 - 07:01

Kiadis Pharma to announce Annual Results for the year ended December 31, 2017 Amsterdam, The Netherlands, March 29, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a [...]

Lexicon Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application (MAA) for Sotagliflozin to Treat Adults With Type 1 Diabetes

29/03/2018 - 07:00

THE WOODLANDS, Texas, March 29, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA [...]

VIFOR PHARMA TO PROPOSE JACQUES THEURILLAT AS BOARD MEMBER

29/03/2018 - 06:54

Jacques Theurillat to be proposed to Annual Shareholder Meeting for appointment to Board Marc de Garidel will not stand for re-election All other members of the Board of Directors will stand for re-election VIFOR PHARMA [...]

Tower One Announces Extension of Warrant Incentive Program

29/03/2018 - 06:03

VANCOUVER, B.C., March 29, 2018 (GLOBE NEWSWIRE) -- Canada Tower One Wireless Corp (CSE:TO) (OTCMKTS:TOWTF) (Frankfurt: A2DKQ4 ) (“Tower One” or the “Company ”) announces, further to its news release dated January 9, [...]

Unum Therapeutics Announces Pricing of Initial Public Offering

29/03/2018 - 03:35

CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX ) (“Unum Therapeutics”), a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products [...]

Sorrento Therapeutics Chairman/CEO update to stockholders

29/03/2018 - 01:28

SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) Dear Sorrento Stockholders, Despite a recent short seller opinion piece aimed at undermining the credibility of Sorrento and its [...]

MediciNova Announces Collaboration with the University of Sydney Concord Cancer Centre to Evaluate MN-166 (ibudilast) in Chemotherapy-Induced Peripheral Neuropathy

29/03/2018 - 01:00

LA JOLLA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875 [...]

Mesoblast Phase 3 Cell Therapy Trial for Chronic Low Back Pain Completes Enrollment

29/03/2018 - 00:25

NEW YORK and MELBOURNE, Australia, March 28, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) today announced that enrollment has completed in the Phase 3 trial evaluating a single intra-discal [...]

Arbutus to Present HBV Data at 2018 EASL Liver Meeting

28/03/2018 - 23:54

VANCOUVER, British Columbia and WARMINSTER, Pa., March 28, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today [...]

Argos Therapeutics to Report Fourth Quarter and Year-End 2017 Financial Results and Operational Highlights on Monday, April 2, 2018

28/03/2018 - 23:00

DURHAM, N.C., March 28, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the [...]

Altimmune Announces Financial Results for the Year Ended December 31, 2017 and Provides Corporate Update

28/03/2018 - 22:44

Conference call and webcast scheduled for tomorrow, March 29 at 8:30am ET GAITHERSBURG, Md., March 28, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, today [...]

Sanofi: Availability of the Pre-quarterly Results Communication

28/03/2018 - 22:31

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Availability of the Pre-quarterly Results Communication Paris, France - March 28, 2018 - Sanofi announced today that its Pre-Quarterly Results Communication [...]

Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »

28/03/2018 - 22:31

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Mise en ligne du document «Pre-quarterly Results Communication » Paris, France - Le 28 mars 2018 - Sanofi annonce la mise en ligne sur l'espace [...]

Amarin to Present at the H.C. Wainwright Annual Global Life Sciences Conference

28/03/2018 - 22:30

BEDMINSTER, N.J. and DUBLIN, Ireland, March 28, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Molecular Templates, Inc. Reports Fourth Quarter 2017 Financial Results

28/03/2018 - 22:30

Update on MT-3724 Provided at World ADC Conference; More Data Expected in 2Q18 Upcoming Presentations at AACR Conference to Feature Data on PD-L1 Antigen Seeding ETB and HER2 ETB AUSTIN, Texas, March 28, 2018 (GLOBE [...]

Revive Therapeutics Retained Mi3 Communications for Investor Relations Services

28/03/2018 - 22:30

TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel [...]

HealthEquity Appoints New Director to the Board

28/03/2018 - 22:07

DRAPER, Utah, March 28, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the nation’s largest health savings account (HSA) non-bank custodian, today announced that its Board [...]